Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000227623 is a **pseudogene** classified as "Pseudogene similar to part of zinc finger, CCHC domain containing 2 (ZCCHC2)." Like most pseudogenes, it is a nonfunctional segment of DNA sharing sequence similarity to an active gene (in this case, ZCCHC2), but it does not produce a functional protein due to disabling mutations or lack of gene expression components[1][2][4]. Pseudogenes can sometimes be transcribed into RNA and, under certain circumstances, may participate in gene regulation by acting as competitive endogenous RNAs or microRNA decoys, but for this specific pseudogene there is no evidence of such biological activity[1][3][4]. It is not considered a therapeutic target, does not encode a receptor, enzyme, or other druggable protein, and is not associated with any established roles as a biomarker or drug interaction partner[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of zinc finger, CCHC domain containing 2.